Corporate Advisory

Trusted, conflict-free advice for corporate boards.

Delivering Tailored Guidance

Public companies turn to us for expert, objective guidance when evaluating major strategic decisions. Our independence and globally aligned structure allow us to provide conflict-free advice that is focused solely on shareholders' interests and aligned with the company's values and strategy.

As one of the world's most trusted and respected advisors, we have extensive experience working with highly sophisticated boards and special committees of premier companies to help them evaluate their strategic alternatives and identify the optimal paths for maximizing shareholder value.

We have assembled the most relevant and leading group of experts across sectors, geographies and products to provide integrated and holistic advice to public companies on matters related to:

  • Sell-side M&A
  • Buy-side M&A
  • Board and special committee advisory
  • Divestitures and spin-offs/split-offs
  • Take-over and activist defense
  • Fairness opinions
  • Strategic alternatives analysis
  • Capital structure optimization
  • Equity and debt capital raising

Whether evaluating a transformative transaction or identifying potential paths forward, corporate boards count on us for unbiased advice and outstanding execution for the full range of acquisition and financing alternatives.

Selected Transactions

$625,000,000

has acquired

a portfolio company of 3i Group

William Blair acted as the exclusive financial advisor to Datwyler Holding AG (SWX:DAE) in connection with its pending acquisition of QSR from Q Holding Company, a portfolio company of 3i Group plc.

Read more
€94,700,000

has agreed to acquire

William Blair acted as the exclusive financial advisor to Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) in connection with its pending acquisition of Acacia Pharma Group plc (EURONEXT: ACPH) by way of a scheme of arrangement for €94.7 million ($104 million) in cash and Eagle Pharmaceuticals stock.

Read more
$670,000,000

Hospitals and Large Physician Practices Business

has agreed to be acquired by

$360,000,000

has been acquired by

$370,000,000

has combined with

a portfolio company of Clayton, Dubilier & Rice

William Blair acted as the exclusive financial advisor to Castlight Health, Inc. (NYSE: CSLT) with its pending combination with Vera Whole Health, Inc and Clayton, Dubilier & Rice.

Read more
$73,500,000

business and related assets of Landec

have been acquired by

William Blair acted as the exclusive financial advisor to Landec Corporation (NasdaqGS: LNDC) on the divestiture of its Eat Smart business.

Read more
Not Disclosed

a subsidiary of Continental Grain Company

has sold its Laurel, Mississippi Poultry Processing Operations to

William Blair acted as the exclusive financial advisor to Wayne Farms, Continental Grain, and Cargill in connection with the sale of its poultry production facility located in Laurel, Mississippi.

Read more
$5,200,000,000

has acquired

William Blair acted as a financial advisor to Clearlake Capital Group, L.P. (Clearlake) in connection with its pending acquisition of Cornerstone OnDemand (NASDAQ: CSOD) (Cornerstone).

Read more
$5,300,000,000

have acquired

$525,000,000

a business unit of ASGN, Inc.

has been acquired by

$235,000,000

has acquired

North American Regions

For More Information

Please contact a member of the corporate advisory team.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures